Omeros | OMER - Собственный капитал и резервы





Собственный капитал и резервы Изменить Дата
Adma Biologics USD 390.32M 86.99M 2026-03
Alnylam Pharmaceuticals USD 1.08B 286.2M 2026-03
BioMarin Pharmaceutical USD 6.21B 125.11M 2026-03
Cytokinetics USD -826.57M 166.94M 2026-03
Gilead Sciences USD 23.52B 897M 2026-03
Heron Therapeutics USD 9.14M 4.15M 2026-03
Immunic USD 151.23M 157.91M 2026-03
Insmed USD 704.85M 34.12M 2026-03
Knight Therapeutics CAD 767.27M 480K 2025-12
MacroGenics USD 21.2M 34.39M 2026-03
Omeros USD -228.68M 15.13M 2025-06
Pacira USD 653.89M 39.22M 2026-03
Pfizer USD 90.1B 3.63B 2026-03
Rockwell Medical USD 30.41M 1.11M 2025-06
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sarepta Therapeutics USD 1.51B 364.48M 2026-03
United Therapeutics USD 5.9B 1.2B 2026-03
Vertex Pharmaceuticals USD 19.36B 696.1M 2026-03
Xoma USD 87.94M 15.5M 2025-09